Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes2018-01-17T17:03:07-05:00

Seasonal variation in immune measurements and MRI markers of disease activity in MS

Seasonal variation in immune measurements and MRI markers of disease activity in MS2018-01-17T17:02:18-05:00

Seasonal variation in immune measurements and MRI markers of disease activity in MS

Seasonal variation in immune measurements and MRI markers of disease activity in MS2018-01-17T17:02:18-05:00

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should Be Treated at the Time of Diagnosis2018-01-17T17:01:24-05:00

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS2018-01-17T17:00:38-05:00